Liverpool ChiroChem (LCC). The home of chiral N-heterocycles.

A chemical technology innovator that produces chiral small molecules for biotech/pharmaceutical R&D. Our specialist products can be used as building blocks, fragments and screening compounds to enable small molecule drug discovery. Our chemical technologies provide efficient access to novel chiral building blocks to allow facile access to new chemical space for hit identification and desirable pharmacokinetic properties for effective lead optimisation. Our proprietary products are ideally suited for DNA-encoded library synthesis and Fragment Based Lead Discovery, which many medicinal chemists consider to be the two leading areas of modern-day drug discovery.